Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor activator. This revolutionary approach holds significant promise for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide enhances insulin secretion and suppresses glucagon release, leading to improved glycemic control. Clinical trials have d